1. Warnakulasuriya, S, and John S. Greenspan. Textbook of Oral Cancer: Prevention, Diagnosis and Management. Cham: Springer, 1st ed. 2020.

2. Feller L, Altini M, Lemmer J. Inflammation in the context of oral cancer. Oral Oncol. 2013 Sep; 49(9): 887 - 892. doi: 10.1016/j.oraloncology.2013.07.003. Epub 2013 Jul 30. PMID: 23910564.

3. Каприн А.Д., Старинский В.В., А.О. Шахзадова, Злокачественные новообразования в России в 2021 году (заболеваемость и смертность) - М.: МНИОИ им. П.А. Герцена - филиал ФГБУ "НМИЦ радиологии" Минздрава России, - 2022. - илл. - 252 с.

4. Пачес А.И. Опухоли головы и шеи. 5-е изд., доп. и перераб. М.: Практическая медицина, 2013. С. 119 - 146.

5. Babu N.H., DeviB.V.L., KadiyalaS. etal. Accuracy of preoperative ultrasonography in measuring tumor thickness and predicting the incidence of cervical lymph node metastasis in oral cancer. J Dr NTR Univers Health Sci 2018; 7(4): 241-4.

6. NCCN Clinical Practice Guidelines in Oncology (NCCN ). Cancer of the Oral Cavity. Version 2.2022.

7. German Guideline Program in Oncology (German Cancer Society, German Cancer Aid, AWMF): oral cavity cancer Long version 3.0, Januar 2021, AWMF Registration Number: 007/100OL, https://www.leitlinienprogramm-onkologie.de/leitlinien/mundhoehlenkarzinom/Accessed.

8. J.-P. Machiels, C. Ren Leemans, W. Golusinski, C. Grau, L. Licitra & V. Gregoire, on behalf of the EHNS Executive Board, ESMO Guidelines Committee and ESTRO Executive Board / Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. - Annals of oncology - Volume 31, Issue 11, 2020, Pages 1462 - 1475, ISSN 0923-7534, https://doi.org/10.1016/j.annonc.2020.07.011.

9. Kim SJ, Pak K, Kim K. Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis. Am J Otolaryngol 2019; 40: 297 - 305.

10. V.Gregoire et al. Oral cavity cancer: diagnosis, treatment and follow-up. Technical Report August 2014.

11. Garrel R, Poissonnet G, Moy Plana A, Fakhry N, Dolivet G, Lallemant B, Sarini J, Vergez S, Guelfucci B, Choussy O, Bastit V, Richard F, Costes V, Landais P, Perriard F, Daures JP, de Verbizier D, Favier V, de Boutray M. Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0 Oral and Oropharyngeal Cancer. J Clin Oncol. 2020 Dec 1; 38(34): 4010 - 4018. doi: 10.1200/JCO.20.01661. Epub 2020 Oct 14. PMID: 33052754.

12. Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative.

13. Boero IJ, Paravati AJ, Xu B, Cohen EE, Mell LK, Le QT, Murphy JD. Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy. J Clin Oncol. 2016 Mar 1; 34(7): 684-90. doi: 10.1200/JCO.2015.63.9898. Epub 2016 Jan 4. PMID: 26729432; PMCID: PMC4872027.

14. Панасейкин Ю.А. Севрюков Ф.Е. Исаев П.А. Васильков С.В. Дербугов Д.Н. Семин Д.Ю. Медведев В.С. Полькин В.В. Каприн А, Д. Иванов С.А. Способ лечения начальных стадий рака полости рта. ИЗ-16 2019126365, 20.08.2019. Патент 2713940 11.02.2020 Бюл. 5.

15. Mazeron J.J., Ardiet J.M., Haie-Meder C. et al. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol 2009; 91(2): 150-6.

16. Брахитерапия/В. Н. Галкин, А. А. Говердовский, И. А. Гулидов [и др.]; МРНЦ им. А.Ф. Цыба - филиал ФГБУ "Национального медицинского исследовательского центра радиологии" Министерства здравоохранения Российской Федерации. - Обнинск: "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации, 2017. - 245 с. - ISBN 978-5-901968-28-4. - EDN YUNRBS.

17. Lacas B, Bourhis J, Overgaard J, et al. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Lancet Oncol 2017;18:1221-1237.

18. Naruse, T., Yanamoto, S., Matsushita, Y. et al (2016). Cetuximab for the treatment of locally advanced and recurrent/metastatic oral cancer: An investigation of distant metastasis. Molecular and Clinical Oncology, 5(2), 246 - 252.

19. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003; 21: 92 - 98.

20. Cooper J.S., Pajak T.F., Forastiere A.A. etal. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004; 350: 1937-44.

21. Cooper J.S., Zhang Q., Pajak T.F. et al. Long-term follow-up of the RTOG 9501 intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2012; 84: 1198-205.

22. Noronha V., Joshi A., Patil V.M. et al. Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial. J Clin Oncol 2017: Jco2 017749457.

23. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010; 11: 21 - 28.

24. Cheng Y-J, Tsai M-H, Chiang C-J, et al. Adjuvant radiotherapy after curative surgery for oral cavity squamous cell carcinoma and treatment effect of timing and duration on outcome-A Taiwan Cancer Registry national database analysis. Cancer Med. 2018; 7: 3073 - 3083.

25. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350: 1945 - 1952.

26. Paris KJ, Spanos WJ Jr, Lindberg RD, et al. Phase I-II study of multiple daily fractions for palliation of advanced head and neck malignancies. Int J Radiat Oncol Biol Phys 1993; 25: 657 - 660.

27. Bourhis J, Sire C, Graff P, et al. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. Lancet Oncol 2012; 13: 145 - 153.

28. Beckmann G.K., Hoppe F., Pfreundner L., Flentje M.P. Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer. Head Neck 2005; 27: 36 - 43.

29. SuntharalingamM, HaasML, ConleyBA, EgorinMJ, LevyS, SivasailamS, HermanJM, JacobsMC, GrayWC, OrdRA, AisnerJA, VanEchoDA. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2000 Apr 1; 47(1): 49 - 56. doi: 10.1016/s0360-3016(00) 00408-9. PMID: 10758304.

30. Taylor SG 4th, Murthy AK, Vannetzel JM, Colin P, Dray M, Caldarelli DD, Shott S, Vokes E, Showel JL, Hutchinson JC, et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol. 1994 Feb; 12(2): 385-95. doi: 10.1200/JCO.1994.12.2.385. PMID: 8113846.

31. Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, Horwitz EM, Glisson BS, Nabell L, Cooper JS, Demas W, Gore E. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol. 2004 Jul 15; 22(14): 2856-64. doi: 10.1200/JCO.2004.12.012. PMID: 15254053.

32. Болотина Л.В., Владимирова Л.Ю., Деньгина Н.В., Новик А.В., Романов И.С. Практические рекомендации по лечению злокачественных опухолей головы и шеи // Злокачественные опухоли: Практические рекомендации RUSSCO #3s2, 2024 URL: https://rosoncoweb.ru/standarts/RUSSCO/2023/2023-06.pdf.

33. Machiels J. P. H. et al. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial //The Lancet Oncology. - 2015. - Т. 16. - N. 5. - С. 583 - 594.

34. Сытов А.В., Лейдерман И.Н., Ломидзе С.В., Нехаев И.В., Хотеев А.Ж. Практические рекомендации по нутритивной поддержке онкологических больных // Злокачественные опухоли: Практические рекомендации RUSSCO #3s2, 2018 (том 8). С. 575 - 583.

35. Arends J., Bachmann P., Baracos V. et al. ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition 2017; 36: 11 - 48.

36. Снеговой А.В., Бесова Н.С., Веселов А.В. и др. Практические рекомендации по нутритивной поддержке у онкологических больных. Злокачественные опухоли 2016; (4; Спецвыпуск 2): 2 - 450.

37. Duguet A., Bachmann P., Lallemand Y. Summary report of the standards, options and recommendations for malnutrition and nutritional assessment in patients with cancer. Br J Cancer 2003; 89(1): 92-7.

38. Снеговой А.В., Лейдерман И.Н., Салтанов А.И., Стрельчук В.Ю. Основные принципы и технологии клинического питания в онкологии: Методическое руководство для врачей. М., 2006.

39. BozzettiF., BozzettiV. Efficacyofenteralandparenteralnutritionincancerpatients. Nestle Nutr Workshop Ser Clin Perform Programme 2005; 10: 127 - 39.

40. Приказ Министерства здравоохранения РФ от 31 июля 2020 г. N 778н "О Порядке организации медицинской реабилитации взрослых" Зарегистрировано в Минюсте РФ 25 сентября 2020 г. Регистрационный N 60039.

41. Иванова Г.Е., Мельникова Е.В., Шмонин А.А., Вербицкая Е.В., Аронов Д.М., Белкин А.А., Беляев А.Ф., Бодрова Р.А., Бубнова М.Г., Буйлова Т.В., Мальцева М.Н., Мишина И.Е., Нестерин К.В., Никифоров В.В., Прокопенко С.В., Сарана А.М.О., Стаховская Л.В., Суворов А.Ю., Хасанова Д.Р., Цыкунов М.Б. и др. Пилотный проект "Развитие системы медицинской реабилитации в Российской Федерации": Предварительные результаты реализации на первом и втором этапах медицинской реабилитации. Вестник восстановительной медицины. 2017. N 2 (78). С. 10 - 15.

42. Iliadis, I.P.I. (2021) Quality of life in cancer survivors after participating in a multidisciplinary rehabilitation program: a pre-post study.

43. Arends J, Strasser F, Gonella S, Solheim TS, Madeddu C, Ravasco P, Buonaccorso L, de van der Schueren MAE, Baldwin C, Chasen M, Ripamonti CI; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Cancer cachexia in adult patients: ESMO Clinical Practice . ESMO Open. 2021 Jun; 6(3): 100092. doi: 10.1016/j.esmoop.2021.100092. PMID: 34144781; PMCID: PMC8233663.

44. MuscaritoliM, ArendsJ, BachmannP, BaracosV, BarthelemyN, BertzH, etal. ESPEN practical guideline: Clinical Nutrition in cancer. Clinical Nutrition. 2021.40; p. 2898 - 2913.

45. Burgos-Mansilla, B.; Galiano-Castillo, N.; Lozano-Lozano, M.; , C.; Lopez-Garzon, M.; Arroyo-Morales, M. Effect of Physical Therapy Modalities on Quality of Life of Head and Neck Cancer Survivors: A Systematic Review with Meta-Analysis. J. Clin. Med. 2021, 10, 4696. https://doi.org/ 10.3390/jcm10204696.

46. GoyalN, DayA, EpsteinJ, GoodmanJ, GraboyesE, JalisiS, KiessAP, KuJA, MillerMC, PanwarA, PatelVA, SaccoA, SandulacheV, WilliamsAM, DeschlerD, FarwellDG, NathanCA, FakhryC, AgrawalN. HeadandneckcancersurvivorshipconsensusstatementfromtheAmericanHeadandNeckSociety. Laryngoscope Investig Otolaryngol. 2021 Nov 30; 7(1): 70 - 92. doi: 10.1002/lio2.702. PMID: 35155786; PMCID: PMC8823162.

47. Kar A, M R A, Bhaumik U, Rao VUS. Psychological issues in head and neck cancer survivors: Need for addressal in rehabilitation. Oral Oncol. 2020 Nov; 110: 104859. doi: 10.1016/j.oraloncology.2020.104859. Epub 2020 Jun 18. PMID: 32564916.

48. ElaldiR, RousselLM, GalJ, SchellerB, ChamoreyE, SchiappaR, Lasne-CardonA, LouisMY, , DassonvilleO, PoissonnetG, SaadaE, BenezeryK, BabinE, BozecA. Correlationsbetweenlong-termqualityoflifeandpatientneedsandconcernsfollowingheadandneckcancertreatmentandtheimpactofpsychologicaldistress. A multicentric cross-sectional study. Eur Arch Otorhinolaryngol. 2021 Jul; 278(7): 2437 - 2445. doi: 10.1007/s00405-020-06326-8. Epub 2020 Sep 8. PMID: 32901366.

49. Dias JF, Oliveira VC, Borges PRT, et al Effectiveness of exercises by telerehabilitation on pain, physical function and quality of life in people with physical disabilities: a systematic review of randomised controlled trials with GRADE recommendations British Journal of Sports Medicine 2021; 55: 155 - 162.

50. Silver J.A., Baima J. Cancer prehabilitation: anopportunity to decrease treatment related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes. Am J Phys Med Rehabil 2013; 92: 715-27.

51. Buffart L.M, Sweegers M.G., May A.M. et al. Targeting exercise interventions to patients with cancer in need: an individual patient data meta-analysis. J Natl Cancer Inst 2018; 110(11): 1190-200.

52. Clarke P., Radford K., Coffey M., Stewart M. Speech and swallow rehabilitation in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 2016; 130(S2): S176-80.

53. Linda Denehy, Lara Edbrooke, The Role of Exercise Before Cancer Treatment, Seminars in Oncology Nursing, 2022, 151330, ISSN 0749-2081, https://doi.org/10.1016/j.soncn.2022.151330.

54. Takenaka Y, Takemoto N, Oya R, Inohara H. Prognostic impact of sarcopenia in patients with head and neck cancer treated with surgery or radiation: A meta-analysis. PLoS One. 2021 Oct 29; 16(10): e0259288. doi: 10.1371/journal.pone.0259288. PMID: 34714876; PMCID: PMC8555817.

55. TalwarB, DonnellyR, SkellyR, DonaldsonM. Nutritionalmanagementinheadandneckcancer: UnitedKingdomNationalMultidisciplinaryGuidelines. J Laryngol Otol. 2016; 130: S32-40.

56. Zhang Y, Tan S, Wu G. ESPEN practical guideline: Clinical nutrition in surgery. Clin Nutr. 2021 Sep; 40(9): 5071. doi: 10.1016/j.clnu.2021.07.012. Epub 2021 Jul 10. PMID: 34455265.

57. Hubera G.F., Dort J.C. Reducing morbidity and complications after major head and neck cancer surgery: the (future) role of enhanced recovery after surgery protocols. Curr Opin Otolaryngol Head Neck Surg 2018; 26(2): 73-5.

58. Coyle, M. J., Main, B., Hughes, C. et al. (2016). Enhanced recovery after surgery (ERAS) for head and neck oncology patients. Clinical Otolaryngology, 41(2), 118 - 126.

59. Midgley A.W., Lowe D., Levy A.R. et al. Exercise program design considerations for head and neck cancer survivors. Eur Arch Otorhinolaryngol 2018; 275(1): 169-79.

60. Swarm R.A., Abernethy A.P., Anghelescu D.L. et al. Adult cancer pain. J Natl Compr Canc Netw 2013; 11(8): 992 - 1022.

61. Goel V., Nemade H., Raju K.V.V.N., Rao C.S. Physiotherapy and Head and Neck Cancers. J Nov Physiother 2017; 7: 337.

62. LogemannJ.A., PauloskiB.R., etal. Speech and Swallowing Rehabilitation for Head and Neck Cancer Patients. ONCOLOGY 11(5): 651 - 659, 1997.

63. Wall L.R., Ward E.C., Cartmill B., Hill A.J. Physiological changes to the swallowing mechanism following (chemo) radiotherapy for head and neck cancer: a systematic review. Dysphagia 2013; 28(4): 481-93.

64. Govender R., Smith C.H., Taylor S.A. et al. Swallowing interventions for the treatment of dysphagia after head and neck cancer: a systematic review of behavioural strategies used to promote patient adherence to swallowing exercises. BMC Cancer 2017; 17(1): 43.

65. Zagari P.R.P.P., Paulon R.M.C., Farias L.P. (2018) Rehabilitation After Tracheostomy. In: de Farias T. (eds) Tracheostomy. Springer, Cham.

66. Starmer, H. M., Ayoub, N., Byward, C. et al. (2017). The impact of developing a speech and swallow rehab program: Improving patient satisfaction and multidisciplinary care. The Laryngoscope, 127(11), 2578 - 2581.

67. WangYH, HuangYA, ChenIH, HouWH, KangYN. Exercise for Trismus Prevention in Patients with Head and Neck Cancer: A Network Meta-Analysis of Randomized Controlled Trials. Healthcare (Basel). 2022 Feb 26; 10(3): 442. doi: 10.3390/healthcare10030442. PMID: 35326920; PMCID: PMC8951417.

68. Matsuda Y, Jayasinghe RD, Zhong H, Arakawa S, Kanno T. Oral Health Management and Rehabilitation for Patients with Oral Cancer: A Narrative Review. Healthcare (Basel). 2022 May 23; 10(5): 960. doi: 10.3390/healthcare10050960. PMID: 35628095; PMCID: PMC9140416.

69. Harris AS. Do patients benefit from physiotherapy for shoulder dysfunction following neck dissection? A systematic review. J Laryngol Otol. 2020 Jan 22: 1 - 5. doi: 10.1017/S0022215120000079. Epub ahead of print. PMID: 31964434.

70. lShareef S, Newton BW. Accessory Nerve Injury. [Updated 2022 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532245/.

71. Fischlechner R, Kofler B, Schartinger VH, Dudas J, Riechelmann H. Does low-level laser therapy affect the survival of patients with head and neck cancer? Lasers Med Sci. 2021 Apr;36(3):599-604. doi: 10.1007/s10103-020-03073-4. Epub 2020 Jun 25. PMID: 32583188.

72. Pauli N., Svensson U., Karlsson T., Finizia C. Exercise intervention for the treatment of trismus in head and neck cancer - a prospective two-year follow-up study. Acta Oncol 2016; 55(6): 686 - 92.

73. Paskett ED, Dean JA, Oliveri JM, Harrop JP. Cancer-related lymphedema risk factors, diagnosis treatment and impact: a review. J Clinl Oncol. 2012; 30(30): 3726 - 3733.

74. Smith B.G., Lewin J.S. Lymphedema management in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 2010; 18(3): 153-8.

75. Vignes S. Lymphedema: from diagnosis to treatment. Rev Med Interne 2017; 38(2): 97 - 105.

76. TacaniP.M., FranceschiniJ.P., TacaniR.E. etal. Retrospective study of the physical therapy modalities applied in head and neck lymphedema treatment. Head Neck 2016; 38(2): 301-8.

77. Lee N., Wigg J., Carroll J.D. The use of low level light therapy in the treatment of head and neck edema. J Lymphoedema 2013; 8(1): 35 - 42.

78. Lynch PT, Horani S, Lee R, Sumer BD, Lee SC, Mayo HG, Rethorst C, Day AT. Effectiveness of physical activity interventions in improving objective and patient-reported outcomes in head and neck cancer survivors: A systematic review. Oral Oncol. 2021 Jun; 117: 105253. doi: 10.1016/j.oraloncology.2021.105253. Epub 2021 Apr 23. PMID: 33901767.

79. FriedJ, EtterJL, StenzelAE, JosephJM, CanniotoR, DanzigerIR, MoysichKB. Physical inactivity and head and neck cancer mortality. Head Neck. 2020 Sep; 42(9): 2516 - 2523. doi: 10.1002/hed.26283. Epub 2020 Jun 1. PMID: 32478442; PMCID: PMC8393317.

80. Baijens, L.W.J., Walshe, M., Aaltonen, LM. etal. European white paper: oropharyngeal dysphagia in head and neck cancer. Eur Arch Otorhinolaryngol 278, 577 - 616 (2021). https://doi.org/10.1007/s00405-020-06507-5.

81. Shao CH, Chiang CC, Huang TW. Exercise therapy for cancer treatment-induced trismus in patients with head and neck cancer: A systematic review and meta-analysis of randomized controlled trials. Radiother Oncol. 2020 Oct; 151: 249 - 255. doi: 10.1016/j.radonc.2020.08.024. Epub 2020 Sep 3. PMID: 32890607.

82. Chee S, Byrnes YM, Chorath KT, Rajasekaran K, Deng J. Interventions for Trismus in Head and Neck Cancer Patients: A Systematic Review of Randomized Controlled Trials. Integr Cancer Ther. 2021 Jan-Dec; 20: 15347354211006474. doi: 10.1177/15347354211006474. PMID: 34014116; PMCID: PMC8145608.

83. McLaughlin TM, Broadhurst JJ, Harris CJ, McGarry S, Keesing SL. A randomized pilot study on self-management in head and neck lymphedema. Laryngoscope Investig Otolaryngol. 2020 Sep 15; 5(5): 879 - 889. doi: 10.1002/lio2.455. PMID: 33134535; PMCID: PMC7585235.

84. TykerA, FrancoJ, MassaST, DesaiSC, WalenSG. Treatment for lymphedema following head and neck cancer therapy: A systematic review. Am J Otolaryngol. 2019 Sep-Oct; 40(5): 761 - 769. doi: 10.1016/j.amjoto.2019.05.024. Epub 2019 May 30. PMID: 31174933.

85. Грушина Т.И. Реабилитация ряда онкологических больных в санаторно-курортных условиях. Вопросы курортологии, физиотерапии и лечебной физической культуры. 2017. N 2, вып 2: С. 52.

86. Ткаченко Г.А. Клинико-психологическое исследование качества жизни больных, страдающих злокачественными новообразованиями челюстно-лицевой области. Вестник психотерапии 2012; 44(49): 57 - 63.

87. Zhao, S. G., Alexander, N. B., Djuric, Z., et al (2015). Maintaining physical activity during head and neck cancer treatment: Results of a pilot controlled trial. Head & Neck, 38 (S1), E1086-E1096.

88. Segal R., Zwaal C., Green E. et al. Exercise for people with cancer: a systematic review. Curr Oncol. 2017 Aug; 24(4): e290-e315.

89. Samuel S.R., Maiya G.A., Fernandes D.J. et al. Effectiveness of exercise-based rehabilitation on functional capacity and quality of life in head and neck cancer patients receiving chemo-radiotherapy. Support Care Cancer 2019.

90. Mustian K.M., Alfano C.M., Heckler C. et al: Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol 2017; 3: 961-8.

91. Kinkead B., Schettler P.J., Larson E.R. et al. Massage therapy decreases cancer-related fatigue: results from a randomized early phase trial. Cancer 2018; 124(3): 546-54.

92. Streckmann F., Zopf E.M., Lehmann H.C. et al: Exercise intervention studies in patients with peripheral neuropathy: a systematic review. Sports Med 2014; 44:1289-304.

93. Lee J.M., Look R.M., Turner C. et al. Low-level laser therapy for chemotherapy-induced peripheral neuropathy. J Clin Oncol 2012; 30(15): 9019.

94. Rick O., von Hehn U., Mikus E. et al. Magnetic field therapy in patients with cytostatics-induced polyneuropathy: a prospective randomized placebo-controlled phase-III study. Bioelectromagnetics 2016: 38(2): 85 - 94.

95. Tonezzer T, Caffaro L.A.M. Effects of transcutaneous electrical nerve stimulation on chemotherapy-induced peripheral neuropathy symptoms (cipn): a preliminary case-control study. J. Phys. Ther. Sci. 29: 685 - 692, 2017.

96. Oberoi S., Zamperlini-Netto G., Beyene J. et al. Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoS One 2014; 9(9): e107418.

97. He M., Zhang B., Shen N., Wu N., Sun J. A systematic review and meta-analysis of the effect of low-level laser therapy (LLLT) on chemotherapy-induced oral mucositis in pediatric and young patients. Eur J Pediatr 2018; 177(1): 7 - 17.

98. Ross M., Fischer-Cartlidge E. Scalp cooling: a literature review of efficacy, safety, and tolerability for chemotherapy-induced alopecia. Clin J Oncol Nurs 2017; 21(2): 226-33.

99. VanRijn-DekkerMI, vandenBoschL, vandenHoekJGM, BijlHP, vanAkenESM, vanderHoornA, OostingSF, HalmosGB, WitjesMJH, vanderLaanHP, LangendijkJA, SteenbakkersRJHM. Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy. Radiother Oncol. 2020 Jun; 147: 103 - 110. doi: 10.1016/j.radonc.2020.03.014. Epub 2020 Apr 3. PMID: 32251949.

100. ByeA, SandmaelJA, SteneGB, ThorsenL, BalstadTR, SolheimTS, PrippAH, OldervollLM. Exercise and Nutrition Interventions in Patients with Head and Neck Cancer during Curative Treatment: A Systematic Review and Meta-Analysis. Nutrients. 2020 Oct 22; 12(11): 3233. doi: 10.3390/nu12113233. PMID: 33105699; PMCID: PMC7690392.

101. FabiA, BhargavaR, FatigoniS, GuglielmoM, HorneberM, RoilaF, WeisJ, JordanK, RipamontiCI; ESMOGuidelinesCommittee. Electronic address: clinicalguidelines@esmo.org. Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment. Ann Oncol. 2020 Jun; 31(6): 713 - 723. doi: 10.1016/j.annonc.2020.02.016. Epub 2020 Mar 12. PMID: 32173483.

102. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain, version 1.2022 - January 19, 2022. Available at https://www.nccn.org/professionals/physician_gls/default.aspx#supportive. Accessed January 25, 2022.

103. JordanB, MarguliesA, CardosoF, CavalettiG, HaugnesHS, JahnP, LeRhunE, PreusserM, , TaphoornMJB, JordanK; ESMOGuidelinesCommittee. Electronic address: clinicalguidelines@esmo.org; EONS Education Working Group. Electronic address: eons.secretariat@cancernurse.eu; EANO Guideline Committee. Electronic address: office@eano.eu. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. 2020 Oct; 31(10): 1306 - 1319. doi: 10.1016/j.annonc.2020.07.003. Epub 2020 Jul 30. PMID: 32739407.

104. MenendezAG, CobbR, CarvajalAR, etal: Effectivenessofmassagetherapyasatreatmentstrategyandpreventivemodalityforchemotherapy-inducedperipheralneuropathysymptoms. 2016 Palliative and Supportive Care in Oncology Symposium. Abstract 193.

105. Bensadoun R.J., Nair R.G. Low-level laser therapy in the management of mucositis and dermatitis induced by cancer therapy. Photomed Laser Surg 2015; 33(10): 487-91.

106. Roopashri G. Radiotherapy and chemotherapy induced oral mucositis - prevention and current therapeutic modalities. IJDA 2010; 2: 174-9.

107. Сопроводительная терапия в онкологии. Практическое руководство. Под ред. С.Ю. Мооркрафта, Д.Л.Ю. Ли, Д. Каннингэма. Пер. с англ. Под ред. А.Д. Каприна. М.: Гэотар, 2016. 432 с.

108. Rosenthal D.I., Trotti A. Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol 2009;19:29-34. Pauloski B.R. Rehabilitation of dysphagia following head and neck cancer. Phys Med Rehabil Clin N Am 2008; 9: 889 - 928.

109. , S.F., Wessel, I., Dalton, S.O. et al. Swallowing Exercise During Head and Neck Cancer Treatment: Results of a Randomized Trial. Dysphagia 37, 749-762 (2022). https://doi.org/10.1007/s00455-021-10320-5.

110. , M., Villar-Taibo, R., Fern ndez-Pombo, A. et al. Early versus conventional nutritional intervention in head and neck cancer patients before radiotherapy: benefits of a fast-track circuit. Eur J Clin Nutr 75, 748-753 (2021)]. https://doi.org/10.1038/s41430-020-00786-1.

111. Сытов А.В., Зузов С.А., Кукош М.Ю., Лейдерман И.Н., Потапов А.Л., Хотеев А.Ж. Практические рекомендации по нутритивной поддержке онкологических больных. Злокачественные опухоли: Практические рекомендации RUSSCO #3s2, 2021 (том 11).

112. RobijnsJ, LodewijckxJ, ClaesS, VanBeverL, PannekoekeL, CensabellaSetal (2021) Photobiomodulationtherapyforthepreventionofacuteradiationdermatitisinheadandneckcancerpatients (DERMISHEADtrial). Radiother Oncol 158: 268 - 275.

113. EladS, ChengKKF, LallaRV, YaromN, HongC, LoganRM, BowenJ, GibsonR, SaundersDP, ZadikY, AriyawardanaA, CorreaME, RannaV, BossiP; MucositisGuidelinesLeadershipGroupoftheMultinationalAssociationofSupportiveCareinCancerandInternationalSocietyofOralOncology (MASCC/ISOO). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020 Oct 1; 126(19): 4423 - 4431. doi: 10.1002/cncr.33100. Epub 2020 Jul 28. Erratum in: Cancer. 2021 Oct 1; 127(19): 3700. PMID: 32786044; PMCID: PMC7540329.

114. Klausner, G., Troussier, I., Canova, CH. et al. Clinical use of photobiomodulation as a supportive care during radiation therapy. Support Care Cancer 30, 13-19 (2022). https://doi.org/10.1007/s00520-021-06518-w.

115. Mercadante V, Jensen SB, Smith DK, Bohlke K, Bauman J, Brennan MT, Coppes RP, Jessen N, Malhotra NK, Murphy B, Rosenthal DI, Vissink A, Wu J, Saunders DP, Peterson DE. Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline. J Clin Oncol. 2021 Sep 1; 39(25): 2825 - 2843. doi: 10.1200/JCO.21.01208. Epub 2021 Jul 20. PMID: 34283635.

116. NiX, TianT, ChenD, LiuL, LiX, LiF, LiangF, ZhaoL. AcupunctureforRadiation-InducedXerostomiainCancerPatients: ASystematicReviewandMeta-Analysis. Integr Cancer Ther. 2020 Jan-Dec; 19: 1534735420980825. doi: 10.1177/1534735420980825. PMID: 33307864; PMCID: PMC7739209.

117. DymackovaR, SelingerovaI, KazdaT, SlavikM, HalamkovaJ, SvajdovaM, SlampaP, SlamaO. EffectofAcupunctureinPainManagementofHeadandNeckCancerRadiotherapy: ProspectiveRandomizedUnicentricStudy. J Clin Med. 2021 Mar 7; 10(5): 1111. doi: 10.3390/jcm10051111. PMID: 33799949; PMCID: PMC7961644.

118. Ravi P, Vaishnavi D, Gnanam A, Krishnakumar Raja VB. The role of hyperbaric oxygen therapy in the prevention and management of radiation-induced complications of the head and neck - a systematic review of literature. J Stomatol Oral Maxillofac Surg. 2017 Dec; 118(6): 359 - 362. doi: 10.1016/j.jormas.2017.07.005. Epub 2017 Aug 22. PMID: 28838774.

119. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5(6): 649 - 655.

120. SelfEM, BumpousJ, ZieglerC, WilsonL, PottsK. Riskfactorsforhemorrhageafterchemoradiationfororopharyngealsquamouscellcarcinoma. JAMA Otolaryngol Head Neck Surg. 2013 Apr; 139(4): 356-61. doi: 10.1001/jamaoto.2013.103. PMID: 23599070.

121. TaunkNK, HafftyBG, Kostis JB, Goyal S. Radiation-induced heart disease: pathologic abnormalities and putative mechanisms. Front Oncol. 2015 Feb 18; 5: 39. doi: 10.3389/fonc.2015.00039. PMID: 25741474; PMCID: PMC4332338. (Self EM, Bumpous J, Ziegler C, Wilson L, Potts K. Risk factors for hemorrhage after chemoradiation for oropharyngeal squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2013 Apr; 139(4): 356-61. doi: 10.1001/jamaoto.2013.103. PMID: 23599070.).

122. Sittel C, Gossmann A, , Superselective embolization as palliative treatment of recurrent hemorrhage in advanced carcinoma of the head and neck. Ann Otol Rhinol Laryngol. 2001; 110(12): 1126 - 1128.

123. Kumra V, Vastola AP, Keiserman S, Lucente FE. Spontaneous tonsillar hemorrhage. Otolaryngol Head Neck Surg. 2001; 124(1): 51 - 52.

124. Smith TP. Embolization in the external carotid artery. J VascIntervRadiol. 2006 Dec; 17(12): 1897-912; quiz 1913. doi: 10.1097/01.RVI.0000247301.64269.27. PMID: 17185685.

125. Kumar T, Yadav V, Ravi K, Ramaswamy K, Patel MH, Kothari K. External Carotid Artery Ligation in Squamous Cell Carcinomas of the Oral Cavity and Oropharynx: an Oncological Emergency. Indian J Surg. 2015 Dec;77(Suppl 3):850-2. doi: 10.1007/s12262-014-1035-4. Epub2014 Jan 23. PMID: 27011469; PMCID: PMC4775627.